"The FDA's speedy approval of WoundStat means that we can get it more quickly into the hands of those who need it most today -- our warfighters in harm's way around the world." said Devinder S. Bawa, chief executive officer of TraumaCure.
Bawa whose firm creates the product goes one to say "The product's effectiveness is particularly important with core body wounds that a tourniquet can't reach. We believe that WoundStat has the potential to provide the military with another important tool to minimize battlefield deaths caused by hemorrhaging."
Kevin Ward, MD, a VCU emergency physician and associate director for VCURES said, "Uncontrolled bleeding continues to be the primary cause of death on the battlefield."
FDA research proves that WoundStat securely and safely stopped potentially deadly arterial hemorrhaging in three minutes, and continued to do so for at least two hours.
"WoundStat's value goes beyond the battlefield," said retired Lieutenant General Ronald Blanck, DO, former Surgeon General of the Army.
Blanck totes the products usefulness in everday medical crises, "It will provide a life-saving tool in everyday civilian emergency situations as well as where advanced medical care is not immediately available, such as accidents in remote terrain and on the high seas, or in unexpected disasters such as earthquakes or explosions."
